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Objectives: The aim of this study was to investigate the electrical properties of ileal Glucagon-like peptide 1 (GLP-1) secreting L-cells using
murine organoid cultures and the electrophysiological and intracellular signaling pathways recruited following activation of the Gaq-coupled free
fatty acid receptors FFA1 and Gas-coupled bile acid receptors GPBAR1.
Methods: Experiments were performed using ileal organoids generated from mice transgenically expressing ﬂuorescent reporters (Epac2-
camps and GCaMP3) under control of the proglucagon promoter. Electrophysiology and single cell imaging were performed on identiﬁed
L-cells in organoids, and GLP-1 secretion from cultured organoids was measured by immunoassay.
Results: The FFA1 ligand TAK-875 triggered L-cell electrical activity, increased intracellular calcium, and activated a depolarizing current that
was blocked by the TRPC3 inhibitor Pyr3. TAK-875 triggered GLP-1 secretion was Pyr3 sensitive, suggesting that the TRPC3 channel links FFA1
activation to calcium elevation and GLP-1 release in L-cells. GPBAR1 agonist triggered PKA-dependent L-type Ca2þ current activation and action
potential ﬁring in L-cells. The combination of TAK-875 and a GPBAR1 agonist triggered synergistic calcium elevation and GLP-1 secretory
responses.
Conclusions: FFA1 and GPBAR1 activation individually increased electrical activity in L-cells by recruiting pathways that include activation of
TRPC3 and L-type voltage-gated Ca2þ channels. Synergy between the pathways activated downstream of these receptors was observed both at
the level of Ca2þ elevation and GLP-1 secretion.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Enteroendocrine cells (EECs) are found scattered along the gastroin-
testinal tract and produce hormones that dynamically link metabolism
and appetite to rates of nutrient absorption. Enteroendocrine L-cells,
for example, produce several hormones with demonstrated or potential
translational impact, including Glucagon-like peptide-1 (GLP-1), which
enhances insulin secretion and satiety [1,2], GLP-2, which promotes
intestinal growth, and Peptide YY (PYY), which reduces appetite. There
is considerable interest in developing pharmacological agents that
target L-cell secretion, with the prediction that they will mimic some of
the beneﬁcial effects of gastric bypass surgery on type 2 diabetes and
obesity, believed to result, at least in part, from elevated GLP-1 and
PYY levels [3]. A better understanding of the molecular mechanisms
underlying stimulus detection and integration in L-cells would critically
beneﬁt this therapeutic approach.Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metab
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nutrients following their digestion in the gut lumen. L-cell glucose
detection is mediated by the coupled uptake of Naþ ions with substrate
by brush border sodium coupled glucose transporters (SGLT1) [4].
Luminal contents are also detected by G-protein coupled receptors
(GPCRs) linked either to Gas (e.g. bile acid detection by the G-protein
coupled bile acid receptor GPBAR-1, also known as TGR5) or Gaq (e.g.
long chain fatty acid detection by the free fatty acid receptor FFA1, also
known as GPR40). Studies on the Gas-coupled receptor GPR119
concluded that its pharmacological activation was insufﬁcient to exert
a metabolic beneﬁt in humans [5], but more recent studies have re-
ported that concomitant activation of Gas and Gaq pathways in L-cells
is a much more effective stimulus of GLP-1 secretion than either
pathway individually [6].
Studying signaling pathways in single L-cells is now possible using
transgenic mouse models exhibiting cell-speciﬁc expression of ﬂuo-
rescent reporters and sensors of intracellular Ca2þ and cAMP [4,7e9].olic Science, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, UK
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Transcriptomic analyses and primary intestinal cultures from these
models have been used to identify and characterize a variety of
detection pathways for nutrients, hormones, and local signaling mol-
ecules [10]. More recently, intestinal organoid cultures have permitted
the growth and regeneration of intestinal epithelium in a 3-dimensional
model system [11], and have been validated for monitoring enter-
oendocrine hormone secretion [12e14].
The objectives of this study were to identify the electrophysiological
and second messenger responses to FFA1 and GPBAR1 activation in
single L-cells. Intestinal organoids from transgenic mouse models
expressing cell speciﬁc ﬂuorescent sensors of cAMP and Ca2þ pro-
vided a consistent source of L-cells that were readily studied by
electrophysiological methods.
2. MATERIALS AND METHODS
2.1. Glucagon reporter organoid lines and primary ileal cultures
This research has been regulated under the Animals (Scientiﬁc Pro-
cedures) Act 1986 Amendment Regulations 2012 following ethical
review by the University of Cambridge Animal Welfare and Ethical
Review Body (AWERB). Ileal intestinal organoid lines were established
from mice expressing the GCaMP3 reporter in Cre expressing cells,
with Cre expressed under the control of the proglucagon promoter
[4,8]. Ileal intestinal organoid lines were also established from mice
expressing the FRET-based cAMP sensor Epac2camps under the
control of the proglucagon promoter [9]. Organoid protocol was
modiﬁed from Sato et al., 2009. Distal (last 10 cm) mouse small in-
testinal tissue (ileal) was opened and washed in ice cold PBS; the
tissue was chopped into 3e5 mm pieces and then further washed in
ice cold PBS. Tissue pieces were placed in ice cold 30 mM EDTA in
PBS for 5 min, transferred to cold PBS and shaken vigorously for 20 s
(fraction 1). EDTA treatment and subsequent PBS shaking was
repeated 2 more times (fraction 2e3) followed by a further 2 times
shaking in PBS alone (fractions 4e5). The fraction with the most crypts
was selected after examination under a microscope, villi structures
were removed by ﬁltering through a 70 mm cell strainer (Thermo Fisher
Scientiﬁc), and the remaining crypts were centrifuged at 200G for
5 min. The crypt pellet was resuspended in Matrigel (200 ml, Corning),
and aliquots were polymerized at 37 C for 30 min in 48-well plates
(Nunc; 15 ml/well). Organoid medium [11] supplemented with 10 mM
ROCK inhibitor y27632 (Tocris) was added to each well. Medium was
changed every 2e3 days, with organoids passaged every 7 days as
previously described [11]. Mixed primary ileal intestinal cultures were
prepared as previously described [15].
2.2. 2D organoid culture
For 2D culture, organoids were collected in ice cold Advanced
DMEM:F12 (ADF) medium (Life Technologies) and centrifuged at 200G
for 5 min. The organoid pellet was broken-up enzymatically with trypLE
(Gibco) for 2 min at 37 C, before being resuspended in ADF containing
10% FBS (Gibco) and 10 mM y27632. If necessary, organoids were
further broken-up by trituration. Resulting single-cells and clusters
were pelleted at 300G for 5 min, re-suspended in organoid medium
(þ10 mM y27632) and seeded onto 2% Matrigel coated glass bottom
dishes (Matek) for imaging experiments, 48-well plates for GLP-1
secretion measurement or plastic dishes for electrophysiology
experiments.
2.3. Expression analysis of L-cell population
RNA sequencing (n ¼ 3 mice) of FACS-puriﬁed L-cells from the ileum
and colon of Glu-Venus mice was performed as described previouslyMOLECULAR METABOLISM 7 (2018) 90e101  2017 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.com[16]. All sequencing was performed at the Transcriptomics and Ge-
nomics Core Facility (Cancer Research UK Cambridge Institute) using
an Ilumina HiSeq 2500 system.
2.4. GLP-1 secretion
For GLP-1 secretion experiments ileal-derived organoids were seeded
into 48-well plates as described above. 1e2 days following seeding,
2D cultures were washed 3 times in warm 138 buffer containing 1 mM
glucose and 0.1% fatty acidefree BSA. Cells were incubated for
20 min in 1 mM glucose in 138-buffer at 37 C, which was completely
removed before test agents dissolved in 150 ml of the same buffer
were added and incubated at 37 C for 2 h. Supernatants were
removed from the organoids and spun at 350G for 5 min at 4 C,
transferred to a fresh tube and snap frozen on dry ice. Meanwhile, the
cells were lysed in 150 ml of lysis buffer on ice for 30 min. Lysates
were scraped and collected, followed by centrifugation at 8000G for
10 min at 4 C, and resulting supernatants snap frozen until mea-
surement. GLP-1 levels were measured using the total GLP-1 ELISA kit
(MesoScale) as per manufacturer instruction. GLP-1 secretion was
calculated ﬁrst as a percentage of individual well content and second
as fold change in comparison to wells treated with 138 buffer without
additions in parallel on each plate (basal, containing 1 mM glucose and
0.1% BSA). To examine potential synergy between FFA1 and GPBAR1
pathways, we added the % of GLP-1 released of single drug treat-
ments (above basal conditions) to give a predicted % of GLP-1
secretion and subtracted this from the observed % of GLP-1
secreted by the simultaneous application of both drugs.
2.5. Immunohistochemistry
Organoids were retrieved from Matrigel using Cell Recovery Solution
(Corning) and ﬁxed in 4% paraformaldehyde in PBS (Alfa Aesar) for
30 min at room temperature. 2D cultures on glass coverslips were
ﬁxed in 4% paraformaldehyde in PBS for 20 min. Immunostaining was
performed as previously described [17]. Rabbit polyclonal antibodies
against proglucagon (Santa Cruz, sc-13091) were used at 1:200 and
goat polyclonal antibodies against GFP (Abcam, ab5450) at 1:1000 to
detect YFP and GCaMP3. Secondary antibodies conjugated to Alexa-
Fluor 488 and 555 (Invitrogen) were used at 1:1000 and Hoescht
(Sigma) nuclear stain at 1:3000.
2.6. Electrophysiology
Ileal organoids or primary ileal cultures were plated as a 2D monolayer
1e3 days prior to recording on 35 mm dishes. Experiments were
performed on single cells or well-deﬁned cells in small clusters.
Membrane potential and currents were recorded in the perforated-
patch conﬁguration using an Axopatch 200B connected through a
Digidata 1440A A/D converter and pCLAMP software (Axon In-
struments). Microelectrodes were pulled from borosilicate glass
(1.5 mm OD, 1.16 mm ID; Harvard Apparatus) and the tips coated with
reﬁned yellow beeswax. Electrodes were ﬁre-polished using a
microforge (Narishige) and had resistances of 2e3 MU when ﬁlled
with pipette solution. A silver/AgCl ground wire connected to the bath
solution via a 0.15 M NaCl agar bridge was used as a ground.
To trigger action potential ﬁring, current was injected to maintain the
cell at 70 mV and 10 ms current pulses, increasing in magnitude by
2 pA, was applied at 0.2 Hz. A peak threshold of 10 mV was used to
positively identify an action potential for further analysis. The action
potential peak was taken as the maximum voltage reached during the
protocol described above. The threshold of action potential ﬁring was
determined as the voltage at which an action potential began its rapid
upstroke. The width of the action potential waveform was measured atopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 91
Original Article50% of the action potential peak, or the action potential half-width. For
pharmacological assessment of the action potential waveform, the
action potential peak was measured after application of channel
blocker and expressed as a % of total block by application of TTX
(0.3 mM) þ Cd2þ (100 mM).
To examine the pattern of action potential ﬁring, current was injected
to maintain the cell at70 mV and 500 ms current steps, sequentially
increasing in amplitude by 2 pA, were injected. The total number of
action potentials that crossed a threshold of 10 mV elicited during
the current injection was plotted against the magnitude of the current
injected.
Inward currents and isolated Ca2þ currents were recorded by applying
a series of 70 ms voltage steps from 110 mV to þ60 mV, from a
holding potential of80 mV. Peak current from the fast or Naþ current
component was determined as the minimum peak current occurring
within 1 ms of the capacitative transient current. The peak current from
the slow or Ca2þ current component was measured from the current
10 ms following the application of a voltage step. ICa-voltage rela-
tionship was assessed with 160 ms voltage ramps, from a holding
potential of 80 mV to þ80 mV. Ten ramps were averaged per
treatment for each cell and normalized to the baseline peak ICa
amplitude.
To investigate hyperpolarization-activated currents (HCN), a series of
2 s voltage steps from 50 to 140 mV was applied from a holding
potential of 50 mV. Currentevoltage relationships were studied by
repeatedly ramping the voltage over 500 ms from 100 to 50 mV,
from a holding potential of 80 mV. Twenty ramps were averaged
before and during application of GPBAR-A.
To measure currents elicited following application of the FFA1 agonist
TAK-875, 120 ms voltage ramps from 120 to 0 mV, from a holding
potential of 70 mV, were applied and at least ten ramps were
averaged for each treatment per cell. Current amplitudes were
measured at 90 mV, subtracted from baseline current measured
before treatment (D current) and compared between treatments.
The inter-spike membrane potential (ISMP) was assessed by ﬁtting a
Gaussian curve to an “all-points” histogram of a 30 s recording of
baseline or treatment. The mean or peak of the ﬁtted curve was taken
as ISMP.
2.7. Microscopy
Immunostained cells were imaged on an SP8 confocal microscope
(Leica Microsystems). In situ organoids were imaged on an EVOS
microscope (Thermo Fisher Scientiﬁc). Time-lapse microscopy of
organoids was imaged using Incucyte Zoom imaging system (Essen
BioScience). Images were processed using LAS-X (Leica), Photoshop
(Adobe), and ImageJ (NIH) software. GCaMP3 and Epac2camps im-
aging experiments were performed as previously described using an
inverted microscope and Metaﬂuor software (Molecular Devices)
[9,15]. For GCaMP3 time-lapse microscopy, images were taken every
2 s. For ﬂuorescence intensity analysis exclusive thresholding and
background subtraction was ﬁrst applied, mean whole cell ﬂuores-
cence intensity was then calculated and a 30 s rolling average was
generated for each trace. Changes in ﬂuorescence intensity were
measured as the difference in max intensity before and during treat-
ment (DFI). For Epac2camps FRET time-lapse microscopy images
were taken every 5 s, whole cell ﬂuorescence intensity of both donor
(CFP) and acceptor (YFP) was measured after exclusive thresholding
and background subtraction was applied. A 30 s rolling average was
generated for the ratio of CFP/YFP and changes in this ratio was
measured as the difference in max ratio before and during treatment
(DCFP/YFP). To determine whether the GCaMP3 response to co-92 MOLECULAR METABOLISM 7 (2018) 90e101  2017 The Authors. Published by Elsevier Gapplication of FFA1 and GPBAR1 agonists was synergistic, we calcu-
lated for every cell what the additive increase in GCaMP3 ﬂuorescence
intensity should be (based on single treatment of each drug on that
cell) and compared this to the actual GCaMP3 ﬂuorescence intensity
produced by co-application of both drugs.
2.8. Solutions, drugs and chemicals
Standard saline solution (138 buffer) used for secretion, imaging, and
electrophysiological experiments consisted of (in mM) NaCl (138), KCl
(4.5), HEPES (10), NaHCO3 (4.2), NaH2PO4 (1.2), D-glucose (1), CaCl2
(2.6), MgCl2 (1.2); pH 7.4 with NaOH. For experiments where a higher
KCl concentration was used (30 mM), the standard saline solution was
adjusted to replace Naþ with Kþ.
For perforated-patch recordings, the internal pipette solution contained
(in mM) K2SO4 (76), NaCl (10), KCl (10), HEPES (10), sucrose (55),
MgCl2 (1); pH 7.2 with KOH. Amphotericin B (2e2.5 mg/mL) dissolved
in DMSO was added to the pipette ﬁlling solution on the day of
recording.
For isolating inward currents, an external recording solution containing
(in mM) NaCl (118), CsCl (5.6), HEPES (10), TEA-Cl (20), D-glucose (1),
CaCl2 (5), pH 7.4 with NaOH, was used. For recording Ca
2þ currents,
the same external solution described above was applied with the
addition of tetrodotoxin or TTX (0.3 mM). The same internal pipette
solution for perforated-patch recordings was used to record inward
currents and isolated Ca2þ currents with the exception of K2SO4,
which was replaced with an equal concentration of Cs2SO4.
Lysis buffer used in secretion assays consisted of (in mM) TriseHCl
(50), NaCl (150), 1% IGEPAL-CA 630, 0.5% deoxycholic acid and
supplemented with complete EDTA-free protease inhibitor cocktail
(Roche).
Unless otherwise stated, all chemicals were purchased from Sigmae
Aldrich. TTX, u-agatoxin-IVA and nifedipine were purchased from
Alomone Laboratories; TAK-875 and isradipine were purchased from
Adooq Bioscience. Drug stocks were made as a 1000 concentrated
stock and diluted to a ﬁnal working concentration on the day of
experiment. Drugs for imaging and electrophysiology experiments
were applied directly onto cells using a custom-made gravity-fed
perfusion system. A constant ﬂow of external solution was applied onto
cells during baseline recordings and switched to a drug solution during
drug applications to avoid ﬂow-induced artifacts. All recordings were
performed at room temperature (20e24 C).
2.9. Statistical analyses
Statistical tests were performed with GraphPad Prism 7 (GraphPad
Software). Individual data points were represented on graphs with the
mean  S.E.M. or median  interquartile range. Statistical signiﬁ-
cance between two groups was determined using an unpaired t-test,
paired t-test or Wilcoxon matched-pairs signed rank test, as indicated.
To compare three or more groups, a one-way analysis of variance
(ANOVA) test followed by the indicated multi-comparison test was
performed. P < 0.05 was considered to represent statistical signiﬁ-
cance. GLP-1 secretion analysis was performed on log transformed
data. For synergy and ﬂuorescence intensity/ratio change analysis, a
one-sample t-test or a Wilcoxon signed-rank test was performed.
3. RESULTS
3.1. Generation of organoids from transgenic mice expressing
ﬂuorescent labels in L-cells
Ileal organoids (each line derived from a single mouse with 2 inde-
pendent lines for each genotype) were generated from micembH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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expressing the FRET-based cAMP sensor Epac2camps or the ﬂuo-
rescent calcium sensor GCaMP3 under the control of the proglucagon
promoter [4,8,9]. Immunoﬂuorescent labeling conﬁrmed that expres-
sion of both sensors was speciﬁc to cells producing proglucagon
(Figure 1AeC), as previously reported for tissue sections from these
mouse lines [4,9]. The morphology of the developing organoids was
similar to that described previously [12]: cysts developed multiple cryptFigure 1: Characterization of Glu-Cre and Glu-Epac2camps ileal organoid lines. Projectio
Cre  GCaMP3 (B) mouse showing immunostaining for Epac2camps or GCaMP3 (green), p
an ileal L-cell expressing both proglucagon and Epac2camps or GCaMP3. (C) Ileal organoid
(FP) and glucagon expression (GCG). (D) Organoid development (cyst to mature organoid) in
(green). (E) 2D organoid-derived cultures from ileal Glu-Epac2camps line immunostained
secretion in 2D ileal organoid cultures in the presence of 1 or 10 mM glucose (gray
Changes in intracellular calcium and cAMP in 2D ileal organoid L-cells using the Glu-Cre 
(FI) over time in an ileal organoid L-cell perfused with 30 mM KCl in 1 mM glucose (blue lin
KCl (n ¼ 13 cells), mean  SEM also shown. (Hi) CFP/YFP ratio over time in an ileal organ
Forskolin and 100 mM IBMX (red line). (Hii) Scatterplot of CFP/YFP ratio changes in respon
shown. Scale bars A, B, and E ¼ 10 mm, D ¼ 500 mm. Statistical analysis performed using
H), p < 0.05 ¼ */y, p < 0.01 ¼ **, p < 0.001 ¼ ***/yyy.
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crypt and villus domains (Figure 1D, Supplemental Movie 1). Organoid
lines were passaged every 7 days and maintained for more than 6
months and have been cryogenically frozen and re-established mul-
tiple times.
Supplementary video related to this article can be found at https://doi.
org/10.1016/j.molmet.2017.11.005.n of a confocal stack of an ileal-derived organoid from a Glu-Epac2camps (A) or Glu-
roglucagon (red) and nuclei (blue). Bottom panels show a single confocal optical slice of
s from Glu-Cre and Glu-Epac2camps lines scored for expression of ﬂuorescent reporter
the ileal Glu-Epac2camps line, showing both brightﬁeld and Epac2camps ﬂuorescence
for Epac2camps (green) and proglucagon (red). (F) Mean  SEM (n ¼ 9) fold GLP-1
or black bar, respectively) compared to buffer with no glucose (white bar). (GeH)
GCaMP3 and Glu-Epac2camps lines, respectively. (Gi) GCaMP3 ﬂuorescence intensity
e) or 1 mM glucose (black line) alone. (Gii) Scatterplot of GCaMP3 FI changes by 30 mM
oid L-cell perfused with 1 mM glucose in the absence (black line) or presence of 10 mM
se to addition of 10 mM Forskolin and 100 mM IBMX (n ¼ 8 cells), mean  SEM also
either a one-way ANOVA with Tukey’s multiple comparison (F) or one sample t-test (Ge
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 93
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dissociated into small cell clusters and plated onto dishes containing a
thin coat of Matrigel (Figure 1E) to produce 2-dimensional (2D) cultures
that brought L-cells into a single focal plane for imaging experiments,
to allow free access for patch clamp electrodes, and to facilitate so-
lution exchanges during live-cell experiments. Similar to both primary
cultures from freshly-isolated intestinal crypts and intact 3D duodenal
organoids [7,12,13], 2D ileal organoid cultures displayed GLP-1
secretory responses to elevated glucose concentrations, indicating
that their constituent L-cells were functionally viable (Figure 1F).
In 2D cultures from Glu-Cre  GCaMP3 organoids, 30 mM KCl trig-
gered a transient increase in GCaMP3 ﬂuorescence consistent with the
opening of voltage-gated Ca2þ channels and Ca2þ inﬂux (Figure 1G). In
Glu-Epac2camps organoids, the combination of forskolin (10 mM) and
IBMX (100 mM) resulted in a robust increase in the CFP/YFP ratio,
consistent with elevation of intracellular cAMP concentrations
(Figure 1H). These results thus validate the GCaMP3 and Epac2camps
reporter organoid lines for monitoring intracellular Ca2þ and cAMP
changes in L-cells, and all further experiments were performed in 2D
cultures.
3.2. Electrical activity of ileal L-cells in primary culture
Electrophysiological recordings from ileal organoid-derived L-cells
were performed in the perforated-patch conﬁguration to preserve
cytoplasmic signaling pathways, revealing that these cells are elec-
trically excitable (Figure 2A and B). Action potentials triggered by short
depolarizing current injections (Figure 2A) had a mean threshold
of 29  2 mV, reached peak potentials of þ18  2 mV, and had
mean action potential half-widths of 29 3 ms (n¼ 21). The majority
of ileal organoid-derived L-cells (24/28 cells) ﬁred spontaneous action
potentials (Figure 2B; range of action potential ﬁring frequency 0.3e
3.5 Hz).
Compared with action potentials from colonic L-cells in primary short-
term culture [18], the waveform of ileal organoid-derived L-cell action
potentials was broader and had a lower peak, suggesting the
involvement of a different proﬁle of voltage-gated currents in ileal
compared with colonic L-cells. To conﬁrm that this difference was not
due to the generation of ileal L-cells in organoid cultures, electro-
physiological recordings were also obtained from ileal L-cells in pri-
mary culture, which are technically more demanding than colonic
primary culture electrophysiological recordings. Action potential
morphology was comparable in organoid-derived and primary ileal L-
cells (Figure S1).
The Naþ channel blocker tetrodotoxin (TTX) had little effect on the action
potential peak of ileal organoid L-cells (Figure 2Cii) but increased the
action potential threshold (Figure 2Civ). By contrast, the action potential
peak in either the presence or absence of TTX was substantially
impaired by the selective P/Q-type Ca2þ channel blocker ueagatoxin-
IVA (0.5 mM, Figure 2Ciii and Cv) or the broad-spectrum Ca2þ channel
blocker cadmium (Cd2þ, 100 mM; Figure S1Aiii). These ﬁndings suggest
that voltage-gated Naþ currents contribute to action potential initiation,
but that peak potentials are predominantly determined by voltage-gated
Ca2þ currents. Application of a selective L-type Ca2þ channel blocker
isradipine (10 mM) had little effect on the action potential peak
(Figure 2Cv). Voltage-clamp recordings revealed the presence of two
types of inward current (Figure 2D): a fast component that was present
in 5/8 cells and ablated by TTX (Figure 2Dii), and a slow current that was
present in all cells and blocked by Cd2þ (Figure 2Diii). The character-
istics of these fast and slow currents are typical for voltage-gated Naþ
and Ca2þ currents, respectively.94 MOLECULAR METABOLISM 7 (2018) 90e101  2017 The Authors. Published by Elsevier GWe examined our RNA sequencing databases to determine the relative
expression of voltage-gated Naþ and Ca2þ channel subunits in FACS-
puriﬁed ileal and colonic L-cells (Figure 2E). Expression levels of the
Naþ channel subunits Scn3a and Scn11a were comparable in ileal and
colonic L-cells. The P/Q-type Ca2þ channel Cacna1a dominated the
Ca2þ channel subunit proﬁle and was more highly expressed in ileal
than colonic L-cells. L-type (Cacna1c) and T-type (Cacna1h) subunits
were also detected but at lower levels. Expression data for auxiliary
subunits of voltage-gated Naþ and Ca2þ channels are shown in
Figure S2AeB. Consistent with these expression proﬁles, ueaga-
toxin-IVA blocked the majority of isolated Ca2þ currents in voltage-
clamp recordings, whereas isradipine had a smaller effect
(Figure 2F). A small component of non-L and P/Q-type current was
suggested by the blockade of the remaining current by Cd2þ.
3.3. Signaling pathways downstream of GPBAR1 in ileal organoid
cultures
2D ileal organoid-derived cultures were treated with agonists targeting
GPBAR1, which is highly expressed in ileal L-cells (Figure 3A) [7]. GLP-
1 secretion was enhanced w3-fold by the bile acid taurodeoxycholic
acid (TDCA), 5-fold by a small molecule GPBAR1 agonist GPBAR-A
[19], and >10-fold by forskolin/IBMX (Figure 3B). These results are
similar to those we reported previously for primary short-term ileal
cultures [15].
As predicted from the previously reported coupling of GPBAR1 to Gas
[6], TDCA or GPBAR-A robustly elevated L-cell cAMP concentrations
(Figure 3C), and, in secretion studies, GPBAR-A-triggered GLP-1
release was blocked by PKA inhibition (Figure 3D). L-cell Ca2þ re-
sponses were triggered by TDCA but not GPBAR-A (Figure 3E), as also
previously observed in primary cultures [15], likely reﬂecting GPBAR1-
independent TDCA effects. Although GPBAR1 has been reported pre-
viously to couple to TRPA1 [20], a channel expressed highly in L-cells
[8], GPBAR-A-triggered GLP-1 secretion was not impaired by TRPA1
inhibition (Figure S3A).
In perforated patch recordings, GPBAR-A did not alter the morphology
of evoked action potentials or affect the inter-spike membrane po-
tential (Figure S3B), but triggered a reversible increase in action po-
tential frequency during prolonged depolarizing current injections
(Figure 4A) that was further enhanced at larger current injections
(Figure 4Aiv). Ramp currentevoltage relationships between 100
and 50 mV did not reveal any measurable conductance changes
(Figure 4Bi), suggesting that the increased ﬁring frequency was not
due to a reduction in background potassium current or increased
voltage-independent inward current. We also did not observe any
recruitment of hyperpolarisation activated (HCN) currents by GPBAR-A
(Figure S3C), and the effect of GPBAR-A on evoked action potential
frequency was unaffected by the HCN-antagonist ZD7288 (10 mM;
Figure 4Biv). We further examined the role of voltage-gated Ca2þ
channels, and found that GPBAR-A increased the peak Ca2þ current
amplitude by 20.2 3.4% (n¼ 12, Figure 4C). This effect of GPBAR-A
was not observed in the presence of the L-type Ca2þ channel blocker
nifedipine (50 mM), suggesting that GPBAR1 activation enhances the
activity of L-type Ca2þ channels, consistent with the known modula-
tion of these ion channels by PKA [21]. We attempted to address
whether GPBAR1-dependent activation of L-type Ca2þ channels was
responsible for the increased action potential frequency during pro-
longed depolarizing pulses, using the inhibitor nifedipine (50 mM) and
verapamil (10 mM). Unfortunately, we observed a sustained depolari-
zation using this protocol in the presence of L-type channel blockers,
possibly reﬂecting previously-reported inhibitory effects of these drugsmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 2: Electrophysiological characterization of organoid-derived ileal L-cells. (A) Perforated-patch current clamp recording of an organoid-derived ileal L-cell, ﬁring action
potentials in response to depolarizing current injections. Current was injected to maintain the cell at 70 mV, and a series of 10 ms current pulses were applied, increasing in
magnitude by 2 pA. The pulse protocol is illustrated below. (B) Perforated-patch current clamp recording of spontaneous action potential ﬁring from an ileal L-cell. (C) Repre-
sentative traces using the same protocol as in (A), before (Ci) and during application of 0.3 mM tetrodotoxin (TTX, Cii) and during application of TTX þ 0.5 mM u-agatoxin-IVA (Ciii).
Dashed line represents the threshold of action potential ﬁring. The insets show spontaneous action potential ﬁring under the same treatment conditions. (Civ) Threshold for action
potential ﬁring (n ¼ 5) and (Cv) % inhibition of action potential peak following application of channel blockers, expressed as a % of total block by application of TTX
(0.3 mM) þ Cd2þ (100 mM). (Di) Inward current from a perforated-patch voltage clamp recording and sample traces following application of 0.3 mM TTX (Dii, orange trace) or
100 mM Cd2þ (Diii, gray trace). Currents were elicited from a series of 70 ms voltage steps from 110 to þ60 mV, from a holding potential of 80 mV. Only the current response
to the þ10 mV voltage step is shown and is illustrated below the current traces. (Div) Peak current amplitude of the fast and slow current components. Gene expression data of Scn
(Ei) or Cacna (Eii) genes by RNA sequencing of FACS-sorted L-cells from mouse ileum (white circles) and colon (black circles). Individual data points represent fragments per
kilobase of transcript per million mapped reads (FPKM) from 1 mouse. Mean values (n ¼ 3) are presented as lines. (Fi) Superimposed Ca2þ currents from an ileal L-cell before and
during exposure to Ca2þ channel blockers. Red trace represents calcium current (ICa) recorded in the presence of u-agatoxin-IVA (0.5 mM), pink trace represents ICa recorded
following subsequent application of isradipine (10 mM), and gray trace represents ICa recorded following application of cadmium (Cd
2þ, 100 mM). Currents were elicited using the
protocol described in (D) and only the current responses to the þ10 mV voltage step are shown. (Fii) Contribution of Ca2þ channel subtype to total Ca2þ current measured. (Fiii) The
peak ICaevoltage relationship for a representative organoid ileal L-cell following application of Ca
2þ channel blockers. Statistical analysis performed using either by Wilcoxon
matched-pairs signed rank test (Civ), one-way ANOVA with Tukey’s multiple comparison (Cv) or multiple t-tests with Holm-Sidak multiple comparisons correction (E),
p < 0.05 ¼ y, p < 0.001 ¼ ***/yyy. Unless otherwise stated, each cell is represented as an individual point and lines on the graph represent mean  SEM.
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Figure 3: Gpbar1 expression and responses to GPBAR1 agonists in 2D ileal organoid-derived L-cells. (A) Expression of Gpbar1 by RNA sequencing of FACS-sorted L-cells (circles)
and non-ﬂuorescent control cells (squares) from mouse ileum (white) and colon (black). Individual data points represent sequencing results from 1 mouse and lines represent
mean  SEM (n ¼ 3). (B) Mean  SEM (n ¼ 9) fold GLP-1 secretion in 2D ileal organoid cultures in the presence of 10 mM TDCA (green bar), 3 mM GPBAR-A (red bar), or 10 mM
Forskolin þ10 mM IBMX (gray bar) compared to 1 mM glucose (basal, black). (C) Changes in intracellular cAMP levels in 2D ileal organoids using the Glu-Epac2camps line. CFP/
YFP ratio over time in response to 3 mM GPBAR-A (Ci, red line) or 10 mM TDCA (Cii, green line) treatment. 10 mM Forskolin þ 100 mM IBMX (gray line) was used as a positive
control stimulus. (Ciii) Scatterplot of DCFP/YFP ratio in ileal L-cells, in response to 3 mM GPBAR-A (n ¼ 7), 10 mM TDCA (n ¼ 7, 3 non-responders not plotted) and 10 mM
Forskolin þ 100 mM IBMX (F þ I) (n ¼ 14). Scatterplot shows individual cell responses with mean  SEM also shown. (D) Mean  SEM (n  9, data pooled from 5 independent
experiments) GLP-1 secretion (fold compared to basal) in 2D ileal organoid cultures in the presence and absence of the PKA inhibitor H-89 (10 or 30 mM) and GPBAR-A (3 mM)
compared to basal (1 mM glucose) as indicated. (E) Changes in intracellular Ca2þ in organoid-derived L-cells. Example traces of changes in GCaMP3 FI over time in response to
3 mM GPBAR-A (Ei, red line) or 10 mM TDCA (Eii, green line) treatment on top of 1 mM glucose, with 100 nM Bombesin (BBS) and/or 30 mM KCl used as a positive control stimulus
(gray line). (Eiii) Scatterplot of changes in GCaMP3 FI in ileal L-cells, in response to 3 mM GPBAR-A (n ¼ 11), 10 mM TDCA (n ¼ 11), 100 nM Bombesin (n ¼ 12) and 30 mM KCl
(n ¼ 14). Scatterplot shows individual cell responses with mean  SEM also shown. Statistical analysis performed using either paired t-test (A), one-way ANOVA with Dunnett’s
multiple comparison (B), a one sample t-test (C and E), or one-way ANOVA with Bonferroni multiple comparisons correction (D), p < 0.05 ¼ y, p < 0.01 ¼ yy, p < 0.001 ¼ ***/
yyy.
Original Articleon voltage-gated potassium channels [22](Figure S4). Evoked action
potential ﬁring was increased by the L-type Ca2þ channel activator
BayK8644 (10 mM; Figure 4D), supporting the hypothesis that
enhanced L-type Ca2þ channel activity could contribute to the
increased action potential ﬁring observed in the presence of GPBAR-A,
although off-target effects of this dihydropyridine-derivative on
voltage-gated potassium channels have also been reported [23].
3.4. Signaling pathways downstream of FFA1 in ileal organoid
cultures
The FFA1 agonist TAK-875 triggered a small increase in GLP-1
secretion at 10 mM and a more robust secretory response at
100 mM, in 2D ileal organoid cultures (Figure 5A), consistent with the96 MOLECULAR METABOLISM 7 (2018) 90e101  2017 The Authors. Published by Elsevier Gexpression of Ffar1 in FACS-puriﬁed ileal L-cells by RNAseq analysis
(Figure 5B). In electrophysiological current clamp recordings, 10 mM
TAK-875 triggered L-cell membrane depolarization by a mean of
14  2 mV, which in 4/9 cells was sufﬁcient to trigger or increase
action potential ﬁring (Figure 5C). In voltage clamp recordings, 10 and
100 mM TAK-875 activated an inward current that was blocked by an
inhibitor of TRPC3 channels, Pyr3 (10 mM; Figure 5D). Furthermore,
Pyr3 reduced GLP-1 secretion triggered by TAK-875 (Figure 5A),
supporting the role of TRPC3 channels downstream of FFA1 activation
in mediating GLP-1 release. TAK-875 (10 mM) additionally reduced the
peak voltage-gated Ca2þ current amplitude by 10.9  1.6% (n ¼ 6,
Figure S5), consistent with the reported inhibition of P/Q-type currents
by Gq coupled receptors [24].mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 4: Electrophysiological responses of organoid-derived ileal L-cells to GPBAR1 agonists. (A) Perforated-patch current clamp recording of an L-cell ﬁring action potentials
evoked by depolarizing current injections before (i), during (ii) and after (iii) application of GPBAR-A (3 mM). Current was injected to maintain the cell at 70 mV, and a series of
500 ms current pulses was applied, increasing in magnitude by 2 pA. (Aiv) Mean number (n ¼ 9) of action potentials (threshold 10 mV) elicited during current injections as in Ai-
iii, with error bars representing SEM. (Bi) Currentevoltage relationship as assessed by voltage ramps over 500 ms from 100 to 50 mV, from a holding potential of 80 mV.
Twenty ramps per condition in each cell (n ¼ 11 cells) were averaged to represent baseline (black trace) and GPBAR-A treatment (3 mM, red trace). Recording of an L-cell studied
by the same protocol as (A), before (Bii), during application of GPBAR-A (3 mM, Biii), and additional application of the HCN channel blocker, ZD7288 (10 mM, Biv). Perforated-patch
voltage clamp recordings of ICa before (Ci), during (Cii) and after (Ciii) application of GPBAR-A (3 mM). (Civ) ICaevoltage relationship of ileal L-cells as assessed with 160 ms voltage
ramps from a holding potential of 80 mV to þ80 mV, during application of GPBAR-A (3 mM) and nifedipine (50 mM). Ten voltage ramps were averaged per treatment for each cell
(n ¼ 6) and normalized to the baseline peak ICa amplitude. Recording of an ileal L-cell, elicited by the same protocol as (A) before (Di), during (Dii) and after (Diii) application of
BayK8644 (10 mM). (Div) Mean number of action potentials (threshold 10 mV) elicited during current injections as in Di-iii, with error bars representing SEM (n ¼ 4). Statistical
signiﬁcance was assessed using multiple t-tests with Holm-Sidak multiple comparisons correction (Aiv and Div), p < 0.05 ¼ y, p < 0.01 ¼ yy, p < 0.001 ¼ yyy.
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Figure 5: FFA1 stimulation recruits TRPC3 in organoid-derived ileal L-cells. (A) Mean  SEM (n ¼ 9) fold GLP-1 secretion in the presence or absence of TAK-875 (10 or 100 mM,
blue bars), Pyr3 (10 mM, striped bars) and GPBAR-A (3 mM, red bars) as indicated compared to basal (1 mM glucose, black bars). (B) Expression of Ffar1 by RNA sequencing in
FACS-sorted L-cells (circles) and non-ﬂuorescent control cells (squares) from mouse ileum (white) and colon (black). Individual data points represent sequencing results from 1
mouse, mean  SEM (n ¼ 3) also shown. (Ci) Perforated-patch current clamp recording of an L-cell during application of TAK-875 (10 mM). (Cii) Change (n ¼ 8) in measured inter-
spike membrane potential (ISMP) during application of TAK-875 (10 mM). (Di) Currentevoltage relationship as assessed by voltage ramps over 120 ms from 120 to 0 mV, from a
holding potential of 70 mV, and (Dii) Scatterplot of changes in current (Dcurrent) in response to 10 mM TAK-875 (n ¼ 6), 100 mM TAK-875 (n ¼ 7), 10 mM Pyr3 (n ¼ 3), and
100 mM TAK-875 þ 10 mM Pyr3 (n ¼ 6). Median  interquartile range shown. Statistical analysis performed using either a one-way ANOVA with Bonferroni multiple comparisons
correction (A), a paired t-test (B and Cii), or Wilcoxon signed rank test (Dii), p < 0.05 ¼ y, p < 0.001 ¼ ***.
Original Article3.5. Interactions between signaling pathways activated by GPBAR1
and FFA1
The lower TAK-875 concentration of 10 mM was selected to investigate
potential synergy with the GPBAR1 pathway. At this concentration,
TAK-875 on its own was a poor stimulus of Ca2þ responses in L-cells
as monitored by GCaMP3 (Figure 6A), and triggered only a small
elevation of GLP-1 secretion (Figure 6Bi). In the presence of GPBAR-A,
co-application of TAK-875 triggered signiﬁcantly larger Ca2þ re-
sponses, which in 7/8 cells analyzed were greater than the additive
effects of GPBAR-A and TAK-875 administered singly (Figure 6Aiieiii).
The combination of GPBAR-A with TAK-875 also evoked a synergistic
increase in GLP-1 secretion that was evident in 12/15 wells tested
across 5 experiments (Figure 6Bii). In contrast, combination of
BayK8644 (1 mM) and TAK-875 (10 mM) did not result in a greater than
additive stimulation of GLP-1 secretion (Figure S4C).
4. DISCUSSION
For this study, we established and characterized ileal organoid lines
from reporter mice expressing biosensors for intracellular calcium and
cAMP levels in proglucagon expressing L-cells. To utilize the model for
multiple assay platforms, we developed a 2D culture method that
recapitulated GLP-1 secretory responses to known stimuli such as
glucose and agonists of GPBAR1 and FFA1 [4,6,7,13,15,25,26]. One of
the main advantages of the 2D organoid-derived cultures was the98 MOLECULAR METABOLISM 7 (2018) 90e101  2017 The Authors. Published by Elsevier Gimproved accessibility of cells to patch-clamp electrodes, which
enabled the electrophysiological characterization of ileal L-cells.
The electrical properties of ileal L-cells were not identical to those
previously described in GLUTag and colonic L-cells [18,27], likely
reﬂecting the observed regional differences in expression proﬁles of
voltage-gated Naþ and Ca2þ channel subunits. Voltage-gated Naþ
channels appeared important for action potential initiation in ileal L-
cells, as the threshold for action potential ﬁring was increased
tow15 mV in the presence of TTX. This new threshold matched the
potential at which voltage-gated Ca2þ currents were observed to
activate, consistent with the ﬁnding that the P/Q-type Ca2þ channel
blocker u-agatoxin-IVA signiﬁcantly lowered the action potential peak
height (Figure 2Ciii). In colonic L-cells, by contrast, we previously re-
ported that voltage-gated Naþ currents were larger and contributed
signiﬁcantly to the action potential peak. In both ileal and colonic L-
cells; however, we observed that Ca2þ-dependent action potential
ﬁring was possible even in the presence of TTX. Differences between
Ca2þ currents in ileal vs colonic L-cells could possibly arise from
altered expression of auxiliary subunits such as a2d1 subunits (Cac-
na2d1), which play a role in channel assembly and trafﬁcking [28] and
were more abundant in ileal than colonic L-cells (Figure S2Aii).
Gpbar1 and Ffar1 were both highly expressed in primary ileal L-cells
(Figures 3A and 5B), consistent with the measured increases in GLP-1
secretion following activation of either receptor in ileal organoid-
derived cultures (Figures 3B and 5A). GPBAR-A elevated cAMP levelsmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 6: Synergistic effects of FFA1 and GPBAR1 on intracellular calcium levels and GLP-1 secretion. (A) Changes in intracellular Ca2þ levels in organoid-derived L-cells using the
Glu-Cre  GCaMP3 line. (Ai) Changes in GCaMP3 FI over time in response to 10 mM TAK-875 (blue line), 3 mM GPBAR-A (red line), co-application of 10 mM TAK-875 and 3 mM
GPBAR-A (purple line) on top of 1 mM glucose, with 30 mM KCl used as a positive control stimulus (gray line). (Aii) Scatterplot of changes in GCaMP3 FI in L-cells, in response to
10 mM TAK-875, 3 mM GPBAR-A, and co-application of 10 mM TAK-875 and 3 mM GPBAR-A. Scatterplot shows individual cell responses with median  interquartile range (n ¼ 8)
shown in black. (Aiii) Measured  expected change in GCaMP3 FI in response to co-application of GPBAR-A and TAK-875 for the cells shown in Aii. (Bi) Mean  SEM (n ¼ 15) fold
GLP-1 secretion during single applications of 10 mM TAK-875 (blue bar), 3 mM GPBAR-A (red bar), and co-application of both drugs (purple bar) compared to basal (1 mM glucose
alone), 10 mM Forskolin þ 10 mM IBMX (gray bar) treatment used as a positive control. (Bii) Measured  expected change in % GLP-1 secretion upon co-application of GPBAR-A
and TAK-875. The gray dashed line (at 0) represents no synergy. Statistical analysis performed using either Wilcoxon signed-rank test (Aii, Bii), one-way ANOVA with Bonferroni’s
multiple comparison (Bi) or one-sample t-test (Aiii), p < 0.05 ¼ y, p < 0.01 ¼ **/yy, p < 0.001 ¼ ***/yyy.and increased evoked action potentials in ileal L-cells. Although cAMP
elevation was linked to activation of HCN currents in GLUTag cells [29],
we did not observe any effect of GPBAR-A on hyperpolarization-
activated or voltage-independent currents in ileal L-cells. GPBAR-1
did, however, increase the activity of L-type Ca2þ currents by
w20%, consistent with previous observations of PKA-dependent
regulation of these channels in other excitable cells [21]. GPBAR1
has been reported to couple to TRPA1 [20], but we observed no effect
of TRPA1-antagonism on GPBAR-A-triggered GLP-1 secretion
(Figure S3A), and in electrophysiological recordings we saw no evi-
dence for the appearance of TRPA1-currents after GPBAR1 activation.
This suggests that TRPA1 activity was low under our culture condi-
tions. Future work will address the role and recruitability of TRPA1 in L-
cells, as its activation would nonetheless increase the excitability of L-MOLECULAR METABOLISM 7 (2018) 90e101  2017 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comcells by driving them closer towards the threshold of voltage-gated
Ca2þ-channel activation.
TAK-875 triggered L-cell membrane depolarization by activating an
inward current that was blocked by the TRPC3 inhibitor Pyr3, sup-
porting previous data suggesting a role for this channel downstream of
FFA1 in L-cells and pancreatic b-cells [30,31]. The TAK-875 triggered
currents were w80% reduced by Pyr3, either reﬂecting incomplete
inhibition of TRPC3 by this drug [32] or indicating a small contribution
of additional conductances. TRPC3 is a non-selective Naþ/Ca2þ
channel [33], activation of which in b-cells was abolished by inhibitors
of PLC or PKC [30]. Despite the depolarizing effect of 10 mM TAK-875
on the L-cell membrane potential, only small L-cell Ca2þ and GLP-1
secretory responses were observed at this drug concentration, and
action potential ﬁring was only triggered in a proportion of L-cells. Theopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 99
Original Articlesmall Ca2þ response might in part be due to the low glucose con-
centration used in these experiments (1 mM), as increased insulin
secretion from pancreatic b-cells by TAK-875 was highly dependent
upon the glucose concentration [30]. At low glucose, the membrane
depolarization triggered by 10 mM TAK-875 might be insufﬁcient to
open enough voltage-gated Ca2þ channels to activate secretion in the
majority of L-cells. Higher TAK-875 concentrations triggered robust
GLP-1 secretory responses, consistent with the activation of a large
depolarizing TRPC3 current.
Simultaneous activation of FFA1 and GPBAR1 synergistically stimu-
lated GLP-1 secretion consistent with previous observations [6],
although the underlying mechanism for the interaction was previously
unknown. Ca2þ responses to co-application of GPBAR-A with TAK-875
(Figure 6A) were also signiﬁcantly greater than the sum of the re-
sponses to the agents added individually, suggesting that synergy
between the signaling pathways occurs, at least in part, before or at
the level of Ca2þ entry. We hypothesize that the synergy between
GPBAR1 and FFA1 on Ca2þ responses arises because the net effect of
GPBAR1 and FFA1 activation is to increase the activity of voltage-gated
Ca2þ channels (20% activation by GPBAR1 vs 11% inhibition by FFA1).
At membrane potentials below the activation threshold for voltage-
gated Ca2þ currents, this has little effect, but when the membrane
is depolarized by FFA1-dependent TRPC3 channel opening, this trig-
gers a larger Ca2þ response. The enhanced activity of L-type channels
by GBAR1-dependent activation and membrane depolarization likely
also contributes to the increase in hormone secretion.
5. CONCLUSIONS
2D cultures produced from murine ileal organoids are a good model
system for studying L-cell function, recapitulating the properties of
freshly cultured ileal epithelium as well as the intact perfused intestine.
Our ﬁnding that GPBAR1 agonists enhanced the response to mem-
brane depolarization triggered by FFA1 agonism is likely a general
mechanism applicable to a variety of stimulus combinations. The ac-
tion of GPBAR1 included PKA-dependent activation of L-type Ca2þ
currents, which have been closely linked to vesicular exocytosis in
pancreatic b-cells [34], and would likely be mimicked by other Gas-
coupled receptors. This, in turn, should enhance the responsiveness to
any depolarizing stimulus, including sodium coupled glucose uptake by
SGLT1, proton coupled dipeptide uptake by PEPT1 and activation of
other Gaq-coupled GPCRs that recruit TRPC3 or alternative non-
selective cation channels. While the electrophysiological integration
of different signals described here seems sufﬁcient to explain the
observed synergistic Ca2þ response observed in the presence of TAK-
875 plus GPBAR-A, we were unable to simulate a synergistic effect on
GLP-1 secretion by the combination of the L-type Ca2þ-channel
activator BayK8644 and TAK-875. Therefore, we believe that other
cAMP targets such as Epac2 (which is highly expressed in L-cells)
likely contribute to L-cell integration of different stimuli at the levels of
GLP-1 secretion, e.g. affecting the pool of readily releasable vesicles,
as has been reported previously in pancreatic b-cells [35].
Both GPBAR1 and FFA1 are under investigation as candidate drug
targets for increasing gut hormone secretion in humans, and thereby
treating conditions such as type 2 diabetes and obesity. Our data
conﬁrm and help to explain previous observations that drug combi-
nations targeting Gas as well as Gaq have greater efﬁcacy on gut
hormone secretion than single agents, and further raise the important
idea that agents activating Gas-coupled receptors are likely to have
synergistic actions with a number of dietary components including100 MOLECULAR METABOLISM 7 (2018) 90e101  2017 The Authors. Published by Elsevier Gglucose, and therefore to exhibit differential effects on GLP-1 secretion
dependent on concomitant food ingestion.
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